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ABSTRACT 
Microgravity offers new ways of handling fluids, gases, and growing mammalian 
cells in efficient suspension cultures. Some conceptual designs for a zero-g 
fermentor were developed as early as 1969. 
signed another system using a cylindrical reactor vessel in which the cells 
and medium are slowly mixed. The reaction chamber is interchangeable and can 
be used for several types of cell cultures. 
unique suspension type cell and recovery apparatus culture systems for bio- 
process technology experiments and production of biological products in mi- 
crogravity. The first space bioreactor has been designed for microprocessor 
control, no gaseous headspace, circulation and resupply of culture medium, 
and slow mixing in very low shear regimes. Various ground-based bioreactors 
are being used to test reactor vessel design, on-line sensors, effects of 
shear, nutrient supply, and waste removal from continuous culture of human 
cells attached to microcarriers. The small (500 ml) bioreactor is being 
constructed for flight experiments in the Shuttle middeck to verify systems 
operation under microgravity conditions and to measure the efficiencies of 
mass transport, gas transfer, oxygen consumption, and control of low shear 
stress on cells. 
In 1976 bioreactor engineers de- 
NASA has methodically developed 
- 
c 
INTRODUCTION 
For several decades, many important pharmaceuticals and other biological 
products have been obtained from large scale culture of microbial cells. 
However, the mass cultivation o f  mammalian cells is much more difficult 
because of their delicate nature and their stringent environment require- 
ments.' In fact, contemporary culture technology is often inadequate in 
attempts to provide the proper conditions for optimum human cell growth 
and cell secretions. During the past 10 years the need for major techno- 
logical improvements in human cell culture has increased because of the 
expanding need for human cell products, such as hormones, enzymes, inter- 
feron, etc., to be used as pharmaceuticals. 
Increased demand for large numbers of cells for virus and cancer research 
has also added impetus to develop practical systems for large scale culture 
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of mammalian cells. Some improvements have been made; however, large scale 
culture systems still have major problems which make human cell culture 
very difficult and often uneconomical .2 
A great deal of excitement has resulted from the recent success in the genet- 
ic reprogramming of bacterial cells to produce human cell products such as 
growth hormones, human insulin, and interferon. 
neering of very complicated molecules is still several years from commercial 
practicality. Products are sti 1 1  contaminated with bacterial proteins and 
DNA fragments producing problems with allergenic or immune reactions to the 
preparation, To date only growth hormone, obtained from genetically engi- 
neered cells, has been approved by the Food and Drug Administration. Another 
limitation is the inability, so far, to genetically code for any glycosylated 
proteins. 
by genetic engineering remain good candidates for production by culture of 
human cells whenever the technological problems are solved. Many diseases 
involving neoplasms, blood clots, hypertension, anemia, emphysemia, growth 
disorders, and others are now considered treatable with pharmaceuticals 
derived from cell culture if only the technology can be improved to make 
1 arge scal e cu 1 tures practical . 9 
However, the genetic engi- 
Certain human cell products which may not be practically produced 
In the NASA bioprocessing laboratories at the Johnson Space Center we have 
evaluated several of the conventional and more recent methods for culturing 
human cells. Our studies involved (1) the definition of the environmental 
conditions that must be controlled to ensure successful growth and mainte- 
nance of human cells under microgravity conditions; (2) the recovery of 
cultured cells and cell products for postflight research; (3) the initial 
isolation or first step in downstream processing which may be used as a 
feeder step to the purification of products by continuous flow electropho- 
resis (CFE) or recirculating isoelectric focusing (RIEF); and (4) the design 
features which must be included to maintain precise control of culture con- 
ditions under microgravity  condition^.^ 
In order to design proper control systems, it was essential that we obtain 
performance data on various component elements o f  the culture apparatus. 
Special emphasis was placed on designs for fluid handling, temperature dis- 
tribution, gas/liquid phase separation, etc., under microgravity conditions. 
We approached these problems by first identifying physical phenomena and 
operational principles of suspension culture which are gravity dependent. 
Then scientific workshops were held to determine which phenomena may be 
altered in microgravi ty to produce significant advantages or disadvantages 
in the culture p r o c e s ~ , ~ ? ~  It became apparent that many physical and bio- 
physical interactions within cell culture systems are poorly understood. 
Several areas appeared to need additional research to better understand 
the importance o f  particular physical interactions which occur in suspen- 
sion culture systems (see table 1-1). 
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EVALUATIONS OF EARTH-BASED CELL CULTURE SYSTEMS 
Classic industrial and research methods of growing human cells have been 
limited to systems which grow and maintain cells in a monolayer. 
is largely due to the anchorage dependence of mammalian cells. 
that virtually all normal human cells must be firmly attached to some suit- 
able surface before they will grow, multiply, and eventually secrete any 
products. Attempts to grow large numbers of cells in the inside surface 
of roller bottles8 and multiplate propagatorsg has permitted moderate scale 
mamnalian cell cultures. 
This 
It appears 
Some additional success has been achieved from growth cells attached to 
spiral wound membranes and to the surface of hollow fiber dialysis bundles, 
in which nutrients can be supplied through the permeable membrane from media 
circulated on the opposite side of the membrane or hollow fiber.1° However, 
these techniques are still greatly restricted by poor surface-to-volume 
(culture medium) ratios. 
layer cultures, namely, (1) growth in only two dimensions (surface area); 
(2) cell proliferation limited by depletion of oxygen and nutrients; 
(3) difficulties with media circulation and volume-to-cell number ratios; 
(4) cell/product recovery; and (5) contamination control are more readily 
solved by using suspension culture. Unfortunately, almost all human cells 
of pharmaceutical interest grow quite poorly in modern suspension culture 
systems. Even when suspension culture o f  mammalian cells is accomplished 
on a small scale the maximum density of cells varies between 5 ~ 1 0 ~  to 3 ~ 1 0 ~  
cells per cm3. 
number achieved in microbial cultures. Since the amount of product formed 
under proper physiological conditions is directly proportional to the number 
of the cells, high cell concentrations are critical to successful commercial 
cultures. 
Some of the major problems associated with mono- 
This concentration is orders of magnitude less than the 
In addition, the necessity to maintain t h e  c e l l s  in a rather dilute nutrient 
media allows sedimentation to occur easily which in turn requires stringent 
mixing. Often the cells cannot tolerate the severe shear forces caused by 
even the best designed agitation systems. Prolific cells growth is also 
limited by the oxygen supply. 
to supply oxygen; however, the bubbles rise and coalesce so quickly that 
dissolution of oxygen is often incomplete during the bubbles' brief residence 
in the culture media. Vigorous bubbling of air causes high shear rates and 
too often produces uncontrolled foaming. 
out of the suspension where they dry out and die. Toxic waste products, cell 
fragments, and autolysis enzymes then fall back into the media where they 
dry out and die. Toxic waste products, cell fragments, and autolysis enzymes 
then fall back into the media where they poison the culture. Surfactants can 
be used to reduce foaming; however, their application is limited because they 
themselves are deleterious to living cells. 
Sparging of air is usually the best method 
Foaming in turn carries cells up 
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In an attempt to overcome the surface-to-volume disadvantages smal 1 (150-180 
micron) Sephadex or DEAE cellulose beads were developed as microcarriers for 
cultured cells.ff~12 Cells are allowed to attach to the surface of the bead, 
then the beads are suspended in the culture vessel. This technique helped 
solve the attachment dependence problem of human cell culture; however, the 
paticular surface of the bead must generally be custom designed to the re- 
quirements of the specific cell to be grown. Sometimes the surface coating 
also acts as a repository for accumulation of cell waste products which in 
turn limits cell longevity. 
We have compared several of the new culture technologies with the well estab- 
lished monolayer culture systems using several types of mammalian cells. 
This experience gave insight into selected features of each technique which 
may be combined into a suspension culture system for mammalian cells. We 
also have tested all of the commercial microcarrier beads (Cytodex, Super- 
beads, etc.) now on the market; however, sedimentation is still a problem 
especially after the cells are attached to the beads. 
from sparging of oxygen also remain. 
to keep the beads suspended is so severe that cells are damaged and dislodged 
from the bead surface by high shear or bead-to-bead collisions. 
Foaming problems 
Often the mechanical mixing required 
Comparisons o f  commercially available microcarrier beads and discussions 
in cell culture workshops indicate that there may be reasons to study cell 
culture technology under conditions of m i c r ~ g r a v i t y . ~ ~ ~  The elimination of 
gravity dependent sedimentation of cells and bubble buoyancy may provide 
new insight into careful control of culture environments. Gentle mixing 
to ensure adequate mass transport could be achieved while maintaining pre- 
cise control of local temperature, pH, dissolved oxygen, shear, nutrient 
mixing, etc., in a manner heretofore not possible in Earth-based laborator- 
ies. Table 1-2 is a list of studies and workshops conducted by the Johnson 
Space Center to identify research topics and experiments which are needed 
to support the development of a suspension type space bioreactor to be used 
for precision control led cell culture studies in microgravity. 
RELATED SPACE EXPERIMENTS AND CELL CULTURE SYSTEMS 
Studies o f  potential advantages of suspension cell culture technology in 
micro-g will only be avoided if any direct effect of this environment on 
cell function is well understood. Early experiments with cells growing under 
weightlessness indicated that the cell density of S. typhimurium was signifi- 
cantly higher than the one obtained in the ground control experiment.13 The 
most noteworthy of several interpretations include the random distribution 
of cells in the culture liquid resulting in enhanced efficiency of nutrient 
transfer into, and waste transport from, the cells. There also could have 
been some improvement in the oxygen supply due to differences in gas-liquid 
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mixing. Only one well controlled experiment has been carried out in growth 
of human WI-38 cells during the Skylab mission.I4 Normal growth was observed 
along with normal mitotic index and subcellular structure. There was a small 
change in glucose utilization, however. This was considered inconclusive by 
the investigators. 
Experiments on Spacelab 1 showed over a 95% reduction in the ability of human 
lymphocytes to respond to ConA mitogen.15 A change in glucose consumption 
was also noted, but not considered significant until experiments could be re- 
peated with an on-board one-g control. Other experiments showed an increase 
in proliferation of Hela cells, chicken embryo fibroblasts and mitogen stimu- 
lated lymphocytes of up to 30% due to hypergravity of 10-g while glucose uti- 
lization rate was unchanged from one-g.16 Experiments on Shuttle missions 7 
and 8 were performed to determine the attachment efficiency of normal human 
kidney cells to collagen-coated microcarrier beads. 
It was expected that the attachment rate would be reduced after mixing in 
microgravity, since the only opportunity would be random collisions while 
the cells and beads floated free in the culture medium. However, the results 
showed a significant increase in attachment for the flight samples versus the 
ground control experirnent,l7 Within 3 hours, the cell attachment (based on 
the average number of single cells per bead) was 50% greater in microgravity 
than on Earth. Once attached, both the flight and ground control cells grew 
at the same rate during the first 25 hours. 
greater among the cells free-floating in weightlessness. Future experiments 
are planned to give greater insight into the attachment mechanisms. 
practical implications include the possibility of seeding microcarrier cul- 
tures in microgravity and the knowledge that cells could reattach to micro- 
carrier if they come off the bead surface in slowly mixed space bioreactors. 
Cell-to-cell attachment was also 
However, 
CONSIDERATIONS FOR CULTURE OF MAMMALIAN CELLS I N  MICROGRAVITY 
The basic approach of NASA scientists to determine what factors must be 
included in the design of detailed cell culture experiments was to have 
industrial bioreactor experts study the merits of suspension cell culture 
systems and their applications in space. The definitive study1* was per- 
formed by Drs. Nyiri and Toth at Fermentation Design, Inc., in 1976. They 
recommended a perfusion reactor system with an external, cell-free, medium- 
circulation loop to provide resupply of oxygen, nutrients, and scavaging of 
waste products using hollow fiber dialysis type membrane systems, The 
studies specified that the development of a dedicated microprocessor control 
system was essential to the proper operation and data acquisition required 
during space flight. Further, they evaluated the commercial potential of 
such a system and identif led several hormones and cell secretory products 
as valuable enough to warrant the extra costs of production in space. 
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Table 1-3 summarizes the general approach taken by the NASA bioprocessing 
program in the development of the first space bioreactor. 
Based on the interest generated by these studies and the results of a 1976 
Colloquim on Bioprocessing in Space,” a formal proposal to develop a space 
biorector flight unit was approved by NASA in 1978. Thereafter, several 
workshops were held with researchers to define experiments and typical sci- 
ence requirements for the design engineers. Major conclusions of the cell 
culture workshops identified several areas wherein the absence of gravity 
dependent phenomena in the culture environment could provide unique insight 
into certain cell functions and interactions between the cell and its micro- 
environment. Table 1-4 shows the various areas where scientists believed 
that cell culture in micro-g could provide new information on the basic bio- 
dynamics of mammalian cells. 
The objectives of the demonstration flight experiments are shown in table 
1-5. Growth of normal human cells was selected because they are anchorage 
dependent and extremely fragile. 
to grow on Earth in suspension culture systems. In space potential advan- 
tages of lack o f  sedimentation and bubble buoyancy could enable operations 
with very gentle mixing and minimum turbulence to reduce shear effects on the 
cells. 
techniques and principles of basic cell culture operation under microgravity 
conditions. 
Therefore, these cells are very difficult 
The basic objective also included exploration o f  product harvesting 
NASA and academic scientists then began a research program to study the spe- 
cific gravity related problems which affected traditional and new cell cul- 
ture techniques involving biosynthesis of cell secretory products. Research 
reactors were developed at two institutions and differences in gravity ef- 
fects on the process technology of culturing cells which grow freely in sus- 
pension were contrasted with problems related to the anchorage dependent 
cells. Table 1-6 shows these steps and the basic consideration for the ini- 
tial design o f  the space bioreactor. 
the systems development and biological systems (enzymes of cells) used to 
test the efficiencies of the prototype devices throughout three phases o f  
development. As refinements were made, sensors added, and mixing techniques 
tested, various industrial process control systems were tested. Cultures 
were maintained for up to 14 days with L1210 cells; however, commercial pro- 
cess control systems were found to be inadequate to maintain the precise 
control required by human cells. 
Table 1-7 illustrates more details of 
SPACE BIOREACTOR DEVELOPMENT 
In recent months, the bioreactor test unit (BTU) has been designed and fab- 
ricated to be accommodated in a volume equivalent to two or three middeck 
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lockers on the Shuttle. 
of the basic unit and sensor systems to verify operations with fast enzyme 
reactions before a major flight experiment is conducted with live kidney 
calls. Designs are also considering accommodations in the Spacelab racks 
or special middeck experiment racks. 
Current concepts call for an early flight test 
The basic functional requirements for culturing human cells on microcarrier 
beads for 7 to 10 days on-orbit are shown in table 1-8. Unique considera- 
tions include no gaseous headspace in the reaction vessel, sensors in the 
medium circulation loop (to eliminate turbulence in the reactor vessel) and 
flow/pressure controls to maintain pressures at or below 20 psia (to elimi- 
nate effects o f  pressure on cell functions). 
also included based on our experience with limited access to biological ex- 
periments in the middeck while the Shuttle is on the launchpad. 
Practical considerations are 
Design and operational requirements for major components of the system are 
listed in table 1-9. The culture vessel design is based on an adaptation of 
two innovations by industrial researchers. We decided to use our own version 
of a spin filter type culture system originally designed by Thayer at Arthur 
0. Little CO.~O This allows continuous removal of cell-free medium from the 
reactor vessel. We also decided to separate the mixing and spinning filter 
functions by using separate magnetic drives which a1 lows independent control 
needed for very slow stirring during the flight portion of the experiment. 
The vessel volume was limited to 500 ml because of the difficulty in main- 
taining a large supply of human epithelial kidney cells from the same lot 
to reduce interexperimental variations. The target shear range for on-orbi t 
operations was determined previously by researchers at Rice University in 
flow chamber studies of shear effects on kidney cells which secrete uro- 
kinase.z0 The cell number to medium ratios must be kept within 125% of the 
most effective static cultures to ensure that the cells will be able to con- 
dition the medium for maximum viability and product secretions. The mixing 
device chosen was based on a recent design by Feder and Tolbert at Monsanto 
Companyz0 using flexible spiral vanes which helped to minimize turbulence and 
bead-to-impellor collision damage. Our designs call for a co-axial arrange- 
ment of the flexible vanes and the spin filter with special designs to allow 
high spin rates on the filter needed for high flow rates (80-100 ml/min) 
of medium withdrawal from the reactor vessel. This unique design is comple- 
mented by provisions for alternating backwash routes using the medium return 
flow to keep the spin filter from clogging. 
Process control considerations include a custom microprocessor control system 
to control the bioreactor to set point values, automatically log sensor data, 
and provide minimum interface with the flight crew. Our requirements include 
the capability to interface with the process controller with a small personal 
computer (via RS-232) which in turn can operate offline to perform statisti- 
cal analysis of data, and prediction of adverse trend interception of alert 
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or alarm set points. 
software commands from the l'supervisory computer" has also been designed into 
the system. 
The capability to update the process controller with 
The flow diagram of the reactor vessel, fluid loop, oxygenator, and the pro- 
tein concentration sideloop is illustrated in figure 1-1. Detailed designs 
will be considered in later papers by Cross and Bowie; however, special men- 
tion should be made for position of the sensor blocks which allows calcula- 
tions of cell metabolism from the difference in DO, and CO, levels in the 
input and the outflow from the reaction vessel. 
add concentrated culture medium, acid or base for pH control, dialysis type 
hollow fiber refeed system (which also can act as a repository for accumu- 
lating metabolic wastes). A microgravity bubble trap has also been included 
to remove any bubbles formed by gas dissolution during temperature or pres- 
sure change and to trap any gas bubbles which may be injected into the medium 
circulation loop should the oxygenator membrane develop a leak during the 
flight. 
serum proteins from growth medium before changeout to maintenance medium when 
cells are confluent and to periodically (every 3 or 4 days) concentrate a 
sample of the circulating medium for product assays. 
Provisions have been made to 
The function of the high molecular weight filter loop is to remove 
PLANNED FLIGHT TESTS 
The initial flight test requirements for the first two missions are shown in 
table 1-10. The selection of human kidney cells is based on some 8 years of 
in-house experience with those epithelial cells which produce urokinase, one 
of the few pharmaceuticals approved for production from normal human cells 
grown in mass culture. Also, our laboratories have extensive experience with 
detailed methods to screen cell lot to ensure that they are normal, healthly, 
and hardy enough to withstand the rigors of space flight experiments. 
cells have also been flown in space several times by our research group in- 
volved in separation of kidney cells in space by free-fluid electrophoresis 
techniques. 
These 
Several concepts for science objectives of planned early flight tests of the 
space bioreactor are listed in table 1-11. The major emphasis is on culture 
in environmental regimes which are impossible in one-g. These include cells 
maintained in a very low shear field provided by slow gentle mixing which is 
possible in microgravity. Another tantilizing area is the culture of cells 
in the liquid phase of a controlled foam or bubbly culture medium comprised 
of oxygen bubbles which have no buoyancy nor do they coalesce readily in mi- 
crogravity. Other suggested experiments involve studies of artificial oxygen 
carrier emulsions and specific cell physiology under quiescent culture condi- 
tions in space. More details are provided in appendix A of the Draft of the 
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Space Bioreactor Science Requirements Document which was handed out for ref- 
erence at this meeting. 
Finally, it should be obvious that experiments involving human cell cultures 
and suspension bioreactors will provide basic engineering data on the design 
considerations required for most apparatus to culture cells in the absence of 
gravity. Once these principles are understood, cell culture systems can be 
developed to provide live cells on-orbit for cell biology and other types of 
bioprocessing related studies in microgravity. 
tages of micro-g be great enough, it is possible that a space bioreactor 
could become the feeder facility in a multistep bioprocessing system, wherein 
the cell products would be harvested from the bioreactor and fed to a 
continuous flow electrophoresis system or other product purification device 
which can isolate pure pharmaceuticals direct from concentrated culture med- 
ium. Already the second phase of this type of bioprocess in space has been 
demonstrated by commercial CFES purifications on STS-4, 6, 7, 8, and other 
flights. Such a multistep bioprocess is a good candidate for commercially 
orientated research on the U.S. Space Station. 
Should the expected advan- 
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TABLE 1-1.- CELL CULTURE RELATED RESEARCH AREAS (DATA IS NEEDED 
BOTH TO IMPROVE CULTURE TECHNOLOGY ON EARTH) 
Microgravity Related Research Needed: 
Upper limits of shear stress on cells 
Minimum shear required for adequate mixing and mass transport 
Details of required microenvironment surrounding the cell 
Effects of shear on gas transport and cell membranes 
Alterations (if any) of transport when bubbles don't coalesce 
Mass transport in the absence of thermal convective mixing 
Causes for attachment dependence and cell energy diverted to this behavior 
TABLE 1-2.- BIOREACTOR STUDIES 
1976 - 1977 "Space Biosynthesis Systems" - Contact NAS9-14961 by Fer- 
mentation Design Inc., Bethlehem, Pennsylvania. Investi- 
gator: L. K. Nyiri, Ph.D. and G. M. Toth, Ph.D. 
1977 Proposal to Develop Experiments for Multipurpose Space Bio- 
reactor System. Proposal X770056, NASA A.O. No. A0-77-3, 
L. K. Nyiri, Ph.D. and Marvin Charles, Ph.D. 
1978 - 1979 "Development of a Space Bioprocessing System for Cell Cul- 
ture." Contract NAS9-15619, Lehigh University, Bethlehem, 
Pennsylvania. Marvin Charles, Ph,D. and L. K. Nyiri, Ph.D. 
1979 "Gel 1 Culture Biosynthesis,Il Contract NAS9-15322, A. 0. 
Little Co., Cambridge, Massachusetts. 
and M. G. Broone, Ph.D. 
Phil Thayer, Ph.D, 
January 1978 M.I.T. Workshop on "The Feasibility of Cell Culture Sys- 
tems for Space Experiments." 
A. D. Little Co. Inc., - Final report NAS9-15322. 
Proceedings summarized by 
June 1979 Salk Institute Workshop on ''Microgravity Cell Culture Sys- 
tems." Proceedings summarized by A. D. Little Co. Inc., - 
Final report NAS9-15322. 
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TABLE 1-2. - Continued 
January 1982 JSC Conference on "Fluid Mechanical Aspects of Cell Culture," 
Rice University. Summary report by Mike Reynolds, Ph.D. 
1982 "A Microprocessor Interface for the Space Bioreactor System." 
Conducted by Robert A. Synder, Ph.D., (NRC Postdoc). 
August 1985 JSC Workshop on "Space Bioreactor Science." A joint NASA, 
academic, and industrial workshop on the development of a 
space bioreactor and potential flight experiments. Proceed- 
ings published in JSC document no. 22264, edited by D. R. 
Morrison, Ph.D., August 1986. 
TABLE 1-3.- SPACE BIOREACTOR 
0 Conceptual studies by academic institutions and industry started in 1976 
0 Cell culture sciences conferences - MIT, Salk Institute, JSC 
0 Industrial consultation with: Monsanto Corp.; Stanford Research Insti- 
tute; MDAC-St. Louis; Biochem Technologies; Fermentation Design, Inc.; 
K. C. Biologicals; Bioreactor, Inc.; Tissue Culture Association; Alton 
Jones Cell Science Center; and Arthur D. Little Co. 
0 Academic meetings with: MIT, Princeton University, University of 
Rochester, University of Mississipi, Stanford University, Rice Uni- 
versity, University of Houston, and Washington School of Medicine 
0 JSC has accumulated 8 years experience with cell cultures and 4 years 
experience with bioreactor breadboard system 
0 JSC will develop two space bioreactor laboratory test units which will 
confirm design requirements for flight units and can be used for hard- 
ware verification flight tests (DSO's) 
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TABLE 1-4.- BIODYNAMICS 
Micro-g environment research on 
Shear stress on cells 
Anchorage dependence - cell attachment 
Gas transf er/gas- 1 i qu i d foams 
Nutrient/waste diffusion 
Intercellular transport 
Growth 
Bioenergetics 
Product secretions 
TABLE 1-5.- SPACE BIOREACTOR 
Objectives 
0 Develop and test prototype system for controlled growth of mammalian cells 
in microgravity 
0 Demonstrate advantages 
- Lack of sedimentation 
- Lack of bubble buoyancy 
- Unconventional controlled mixing at slow speeds to keep shear at 
minimum 
- Culture of extremely fragile cells 
- Precise control of gas/liquid transport, nutrients, and waste 
- Evaluate new methods of 02 control 
0 Develop continuous culture methods and product harvesting techniques 
0 Provide a basic cell culture and maintenance facility for support of 
cell biology experiments (Shuttle, Spacelab, and Space Station) 
0 Provide a testbed capability to explore other types of cell culture 
including hybridoma cultures, yeast fermentation, etc. 
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TABLE 1-6.- BIOSYNTHESIS 
Gravity Problems Identified 
0 Comparison of culture techniques 
- Monolayer/multiplate 
- Hollow fiber 
- Spin filter suspension 
- Microcarriers 
Development of research bioreactor 
0 Suspension cultures 
- L1210 
- Hybridoma 
- Kidney 
0 Attached human cells 
Development of space bioreactor 
0 Spin filter/microcarriers 
0 No headspace 
0 Micro-g fluid handling 
TABLE 1-7.- SPACE BIOREACTOR 
Phase I - Breadboard 
Systems Development Bioloqical Test System 
Spin filter system - (no headspace) 
Sensor qualification 0 Nutrient consumption 
Fluid circulation loop 0 Nutrient supply 
Temperatures control 0 Culture medium components 
0,, CO, - gas input systems 
Sterilization 
Enzyme reactions 
Phase I1 - Research Bioreactor 
Systems Development Bioloqical Test System 
Refined sensor development data logging Suspension culture - L1210 cells 
Nutrient consumption 0 Maintenance requirements less 
Growth and upper limits to cell mass 0 Less complex culture media 
Stir/mixing techniques 0 Easier for cell counting 
Microprocessor feedback control Attached cells - microcarrier beads 
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TABLE 1-7. - Continued 
Phase I11 - Research Bioreactor 
Systems Devel otment Bioloqical Test System 
Bioreactor test unit (middeck) 
0 Culture chamber + fluid circ. 0 Fast reaction to test sensor and 
0 Minimum sensors recorded data Suspended cell s (L1210) 
Bioreactor - flight unit 0 Human kidney cells on beads 
0 A1 1 up system/microprocessor 0 Pituitary cells on beads 
0 Precision control for human 
Enzyme reaction 
1 oop 
on-orbi t Attached cells 
set limit type feedback control 
control 
cells attached to microcarrier 
beads 
0 1 Spacelab rack or 3 middeck 
lockers 
TABLE 1-8.- BIOREACTOR: BASIC FUNCTIONAL REQUIREMENTS 
S-ystem Requirements 
0 
0 
0 
Basic design - cells on microcarriers 
No headspace in reactor vessel 
Cell/bead free media circulation loop 
- Oxygenation 
- Resupply nutrients 
- Remove toxic waste 
- Product removal 
- In-line sensors 
Autoclave entire core bioreactor 
Pressure on cells <-- 5 psi 
System pressure - up to 15 psi 
Core bioreactor loaded at KSC/installed at L-10 hours 
Self-sufficient process controller - standard operations and alarms 
Separate supervisory computer 
Target core bioreactor - 2 lockers 
Process control ler/support electronics - 1-2 lockers 
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TABLE 1-9.- MAJOR COMPONENT REQUIREMENTS 
Reactor vessel - Separate devices for spin filter and mixing 
- 500 ml culture volume 
- Minimum internal components 
- Control maximum shear 10-40 dynes/cm2 
- Basic test vessel - spin filter (must be kept clean) 
- Marine impellor vs. spiral vanes 
Approach 
Process controller - Onboard CPU/operating system 
- Log all data 12-24 hours 
- Minimum trend projections 
- Interface (RS-232) with supervisory computer 
- Minimum crew interactions 
- Update with software commands 
Approach - Test commercial systems - none adequate 
- Build custom system 
- Buy MDAC ECCM 
Supervisory computer - Off-line data analysis 
- Complicated trend projections 
- Graphics 
Approach - IBM-AT (ground) and lap computer for flight 
TABLE 1-10.- BIOREACTOR TEST REQUIREMENTS 
First fliqht test - No cells 
- Minimum contamination control 
- Test - fluid system 
- Mixing 
- Sensors 
- HMW filter system 
Second fliqht test - Culture feasibility demonstration 
- 7-8 day mission 
- Kidney cells on microcarriers 
- Grow on beads before flight (growth medium) 
- Maintain cells on UKPM (serum free) 
- Exercise HMW filter on 4-day intervals 
- Replenish medium with new medium or dialysis refeed 
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TABLE 1-10.- Continued 
Later fliqhts - Grow cells on microcarriers, then switch to serum- 
free medium 
- Other reaction vessels 
- Hybridomas 
- Fermentation (yeast) 
TABLE 1-11.- EXPERIMENTS WITH HUMAN CELLS (ATTACHED TO MICROCARRIERS) 
Effects of shear stress 
0 Low shear 10-40 dynes/cm2 
0 Target exact shear range to stimulate UK secretions 
0 Direct measure of metabolism - fluromeasure system 
Culture in a controlled foam in the absence of buoyancy 
0 Create stable foam of 0, bubbles in culture medium 
0 Grow cells in liquid phase 
0 Provide continual and intermediate access to 0, supply without cells ever 
being exposed to gas phase 
0 Completely avoid use of anti-foaming agents 
Use o f  fluorocarbon oxyqen carriers in absence of density-driven separation 
0 Use o f  perfluorinated cabon solvents (S.G. 1.87) 
0 Maintain a long-term stable dispersion to carry 0, from oxygenator to the 
cells in reactor vessel 
0 Explore use of serum in media where foaming will not be present as in 
Earth-based systems 
OTHER EXPERIMENTS TO DETERMINE DIRECT CELLULAR EFFECTS 
0 Alterations of cell physiology or morphology 
0 Cell secretions in microgravity - GH, UK 
0 Cellular effects of magnetic fields in absence of gravity 
0 Alterations in cytoskeleton, cell motility 
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